Identification of multi-omics molecular programs from the peripheral circulation of patients with PAH.
文献摘要
Pulmonary arterial hypertension (PAH) involves progressive remodeling of the pulmonary vasculature and right ventricle, yet much of our understanding of disease progression relies on rodent studies because opportunities for investigation in humans are limited. We integrated plasma proteomic, metabolomic, and lipidomic profiles from 402 patients with PAH and 76 healthy controls using latent-network discovery and graphical modeling, with validation in an external cohort and comparison with human and bovine tissue. PAH was associated with broad molecular remodeling across peptides, metabolites, and lipids, with multiple multi-Omic programs converging on disruptions in the TCA cycle. Of note, elevated 2-hydroxyglutarate distinguished PAH across etiologies and comorbidity profiles, was associated with survival and treatment intensity, and was replicated externally. Related TCA-cycle changes were also observed in pulmonary vascular stromal and immune cells. These findings reveal coordinated remodeling across multiple molecular axes and highlight plasma multi-omics as a bridge between clinical phenotypes and tissue-level metabolic reprogramming.